Home
Vir Biotechnology VIR paid Forbes-Tate $50K for lobbying in Q2 2024 · Health Issues, Government Issues and 1 more issue
Trade details
- Type
- Lobbying report
- Amount
- $50,000
- Quarter
- Q2 2024
- Client
- Vir Biotechnology
- Reported
- 24/07/14
Up 0.0% from last quarter
What else happened in Vir Biotechnology around then
Filed or reported within 30 days of the trade day · 24/05/31~24/07/30Vir Biotechnology's other lobbying reports
- Vir Biotechnology
LobbyingVir Biotechnology
LobbyingVir Biotechnology
VIR
$50K
$50K
Reported 07/20
for Q2
- Vir Biotechnology
LobbyingVir Biotechnology
LobbyingVir Biotechnology
VIR
$50K
$50K
Reported 04/19
for Q1
- Vir Biotechnology
LobbyingVir Biotechnology
LobbyingVir Biotechnology
VIR
$50K
$50K
Reported 01/17
for Q4 2025
- Vir Biotechnology
LobbyingVir Biotechnology
LobbyingVir Biotechnology
VIR
$50K
$50K
Reported 25/10/18
for Q3 2025
- Vir Biotechnology
LobbyingVir Biotechnology
LobbyingVir Biotechnology
VIR
$50K
$50K
Reported 25/07/18
for Q2 2025